http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8562575-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8c9e51c8bc1c2fc9abfd96397583939 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78df28fe901fdfd9a5e54d0091513701 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0041 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00 |
| filingDate | 2012-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a081ff96ed2c95b2efce0537458990d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98c040150af1a028dc5bd2a0efa49905 |
| publicationDate | 2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-8562575-B2 |
| titleOfInvention | Holistic breast patch |
| abstract | The Holistic Breast Patch is the first known, non-pharmaceutical, effective device available which inhibits prolactin production safely and aids the relief of discomfort from breast engorgement pain by drying breast milk after pregnancy. The benefits of treatment of prolactin dependent diseases remain to be fully disclosed. It works transdermally and is comprised of a unique, approximately 1½ inch by ¾ inch natural and organic carbonyl disc housed within cotton gauze and nonstick adhesive Telfa®. It meets the Federal Drug Administration's definition of a non-significant risk device (21 CFR 812). Its use will aid in the treatment of prolactin dependent diseases and conditions and eliminate the serious risks of health complications and fatalities that have been documented by the use of prescription drugs, hormones and pharmaceuticals lacking FDA approval for this use by women. Wearing the Patch device is both easy and convenient. Using it as directed expedites the suppression of lactation, significantly reducing the duration of lactation and also alleviates pain associated with breast milk engorgement, in addition to the benefits derived from use in prolactin dependent and related disease treatment. |
| priorityDate | 2012-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 233.